China vaccine market is divided into public and private vaccine market. Public market is classified by Category 1 whereas and Private vaccines included in Category 2. Vaccines in the public market are regulated by PRC government and generally given free of cost by provincial CDC whereas private vaccine market is dominating by private vaccine companies. As a result, private vaccines prices are higher. China vaccine market has faced several scandals in past couple of years which certainly hinder the vaccine market growth.
This report titled “China Vaccine Market & Doses Forecast By Sector (Private, Public), Disease Type (Meningococcal Meningitis, Pneumococcal, DTP, Ebola, Rabies, Others), Products (MCV4, MPSV4, MCV2-Hib, MCV2, MPSV2 and Men A, PCV13, PPV23, Others), Company (Sinopharm Group, Sinovac Biotech, Beijing Tiantan Biological Products Corp Ltd, Chongqing Zhifei Biological Products Co Ltd, Hualan Biological Engineering Inc, Liaoning Chengda Co Ltd, Walvax Biotechnology Co Ltd)” provides a complete analysis of China Vaccine Market.
Sectors - Vaccine Market & Doses in China
- Public
- Private
Disease Type Market - Meningococcal Meningitis, Pneumococcal and DTP Vaccine Market has significant Market Share in China Vaccine Market
On the basis of disease type, Meningococcal meningitis, Pneumococcal and DTP Vaccine market is expected to control major portion of China vaccine market. Vaccine market in China is segmented into Meningococcal meningitis, Pneumococcal, DTP, Ebola, Rabies & Others.
Products - PCV13 Drives Vaccine Market in China
In terms of products, PCV13 hold the maximum share of the China vaccine market. It is predicted that PCV13 will maintain their leading place during the forecasting period as well. Products included in this report are as follows:
- MCV4
- MPSV4
- MCV2-Hib
- MCV2
- MPSV2 and Men A
- PCV13
- PPV23
Public and Private Vaccine Market & Doses
This report provides the detailed analysis of public and private vaccine market in China. Report also provides private and public vaccine doses in China.
Company Analysis
All the companies covered in the report has been covered from the following points
- Overview
- Recent Development
- Vaccine Pipeline
- Revenue Analysis
Key Company Covered - China Vaccine Market
- Sinopharm Group (China National Biotec Group Company Limited)
- Sinovac Biotech, Beijing Tiantan Biological Products Corp Ltd
- Chongqing Zhifei Biological Products Co Ltd
- Hualan Biological Engineering Inc
- Liaoning Chengda Co Ltd
- Walvax Biotechnology Co Ltd
Table of Contents
Companies Mentioned
- Sinopharm Group (China National Biotec Group Company Limited)
- Sinovac Biotech, Beijing Tiantan Biological Products Corp Ltd
- Chongqing Zhifei Biological Products Co Ltd
- Hualan Biological Engineering Inc
- Liaoning Chengda Co Ltd
- Walvax Biotechnology Co Ltd
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...